Susceptibility of HIV-2 to approved and experimental antiretroviral drugs: implications for treatment

被引：0
|
作者：
Witvrouw, M
Pannecouque, C
De Clercq, E
Switzer, WM
Folks, TM
Heneine, W
机构：
[1] Katholieke Univ Leuven, Rega Inst Med Res, Louvain, Belgium
[2] Ctr Dis Control & Prevent, Atlanta, GA USA
来源：
ANTIVIRAL THERAPY | 2002年 / 7卷
关键词：
D O I：
暂无
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
143
引用
收藏
页码：S155 / S155
页数：1
相关论文
共 50 条
  • [41] Antiretroviral therapy response among HIV-2 infected patients: a systematic review
    Ekouevi, Didier K.
    Tchounga, Boris K.
    Coffie, Patrick A.
    Tegbe, Joseph
    Anderson, Alexandra M.
    Gottlieb, Geoffrey S.
    Vitoria, Marco
    Dabis, Francois
    Eholie, Serge P.
    BMC INFECTIOUS DISEASES, 2014, 14
  • [42] Antiretroviral therapy response among HIV-2 infected patients: a systematic review
    Didier K Ekouevi
    Boris K Tchounga
    Patrick A Coffie
    Joseph Tegbe
    Alexandra M Anderson
    Geoffrey S Gottlieb
    Marco Vitoria
    François Dabis
    Serge P Eholie
    BMC Infectious Diseases, 14
  • [43] Antiretroviral therapy in HIV-2 infected patients in the Netherlands: results in 17 patients
    van der Ende, ME
    Brinkman, K
    Keuters, M
    Prins, JM
    Danner, SA
    Osterhaus, ADME
    Schutten, M
    AIDS, 2000, 14 : S104 - S104
  • [44] Antiretroviral drug-resistant HIV-2 infection - a new therapeutic dilemma
    Maniar, Janak K.
    Damond, Florence
    Kamath, Ratnakar R.
    Mandalia, Sundhiya
    Surjushe, Amar
    INTERNATIONAL JOURNAL OF STD & AIDS, 2006, 17 (11) : 781 - 782
  • [45] Treatment of HIV infection: Current recommendations for the use of antiretroviral drugs
    Yeni, P
    IMPLICATIONS OF ANTIRETROVIRAL TREATMENTS, 1997, : 27 - 30
  • [46] PERSPECTIVES ON THE USE OF ANTIRETROVIRAL DRUGS IN THE TREATMENT OF HIV-INFECTION
    VOLBERDING, PD
    INFECTIOUS DISEASE CLINICS OF NORTH AMERICA, 1994, 8 (02) : 303 - 317
  • [47] Replication capacity and drug susceptibility of lopinavir-resistant HIV-2
    Mo, H.
    Lu, X.
    Masse, S.
    Dekhtyar, T.
    Lu, L.
    Mondal, R.
    Koev, G.
    Ng, T.
    Bernstein, B.
    Gao, F.
    Molla, A.
    ANTIVIRAL THERAPY, 2006, 11 (05) : S49 - S49
  • [48] Complex Patterns of Protease Inhibitor Resistance among Antiretroviral Treatment-Experienced HIV-2 Patients from Senegal: Implications for Second-Line Therapy
    Raugi, Dana N.
    Smith, Robert A.
    Ba, Selly
    Toure, Macoumba
    Traore, Fatou
    Sall, Fatima
    Pan, Charlotte
    Blankenship, Lindsey
    Montano, Alexandra
    Olson, Julia
    Badiane, Ndeye Mery Dia
    Mullins, James I.
    Kiviat, Nancy B.
    Hawes, Stephen E.
    Sow, Papa Salif
    Gottlieb, Geoffrey S.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2013, 57 (06) : 2751 - 2760
  • [49] Early treatment failure with lenacapavir in HIV-2 infection
    Obermeier, Martin
    Yildirim, Oezlem
    Ehret, Robert
    Almahfoud, Maher
    Berzow, Dirk
    Kruedewagen, Bernhard
    Degen, Olaf
    JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2024, 27 : 144 - 146
  • [50] Closing the equity gap in the treatment of HIV-2 infection
    Rowland-Jones, Sarah
    Gea-Mallorqui, Ester
    LANCET HIV, 2024, 11 (06): : e347 - e349
12345